E-LIB Suche - Ergebnisse für: Sallman, D. A.

1

PREDICTION OF POST-TRANSPLANT RELAPSE IN THE MYELODYSPLASTI..:

Chung, S. ; Kroger, B. ; Huang, Y....
Leukemia Research Reports. 21 (2024) - p. 100434 , 2024

Link: https://doi.org/10.1016/..

2

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III:..:

Garcia-Manero, G. ; Bachiashvili, K. ; Griffiths, E....
Leukemia Research. 128 (2023) - p. 107270 , 2023

Link: https://doi.org/10.1016/..

3

THERAPY OF TP53 MUT MDS:

Sallman, D.
Leukemia Research. 128 (2023) - p. 107102 , 2023

Link: https://doi.org/10.1016/..

4

Topic: AS08-Treatment/AS08b-Current treatment options – Low..:

Garcia-Manero, G. ; Bachiashvili, K. ; Amin, H....
Leukemia Research. 128 (2023) - p. 107263 , 2023

Link: https://doi.org/10.1016/..

5

P553: A PHASE 2, OPEN-LABEL, MULTIARM, MULTICENTER STUDY TO..:

Vyas, P. ; Daver, N. G. ; Chao, M. P....
HemaSphere. 6 (2022) - p. 452-453 , 2022

Link: https://doi.org/10.1097/..

6

S129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INH..:

Garcia-Manero, G. ; Winer, E. S. ; DeAngelo, D. J....
HemaSphere. 6 (2022) - p. 30-31 , 2022

Link: https://doi.org/10.1097/..

7

P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS F..:

Zeidan, A. M. ; Al-Kali, A. ; Borate, U....
HemaSphere. 6 (2022) - p. 682-683 , 2022

Link: https://doi.org/10.1097/..

8

P1073: MUTATIONAL LANDSCAPE AND CLINICAL OUTCOMES OF PATIEN..:

Zhang, Y. ; Nguyen, L. ; Lu, C....
HemaSphere. 6 (2022) - p. 963-964 , 2022

Link: https://doi.org/10.1097/..

9

S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-..:

Daver, N. G. ; Vyas, P. ; Kambhampati, S....
HemaSphere. 6 (2022) - p. 33-34 , 2022

Link: https://doi.org/10.1097/..

10

S166: MAGROLIMAB IN COMBINATION WITH AZACITIDINE FOR PATIEN..:

Sallman, D. A. ; Al Malki, M. M. ; Asch, A. S....
HemaSphere. 6 (2022) - p. 67-68 , 2022

Link: https://doi.org/10.1097/..

11

PB1922: EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER-RI..:

Rajakumaraswamy, N. ; Gandhi, M. ; Wei, A. H....
HemaSphere. 6 (2022) - p. 1801-1802 , 2022

Link: https://doi.org/10.1097/..

12

P755: HYPERFERRITINEMIA IS A PREDICTIVE BIOMARKER OF POOR C..:

Aguirre, L. E. ; Ball, S. ; Jain, A....
HemaSphere. 6 (2022) - p. 650-651 , 2022

Link: https://doi.org/10.1097/..

13

P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING TH..:

Daver, N. G. ; Vyas, P. ; Chao, M. P....
HemaSphere. 6 (2022) - p. 450-451 , 2022

Link: https://doi.org/10.1097/..

14

P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHE..:

Hasegawa, K. ; Wei, A. H. ; Garcia-Manero, G....
HemaSphere. 6 (2022) - p. 669-670 , 2022

Link: https://doi.org/10.1097/..

15

P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBST..:

DiNardo, C. D. ; Foran, J. M. ; Watts, J. M....
HemaSphere. 6 (2022) - p. 660-661 , 2022

Link: https://doi.org/10.1097/..